Identification of intermediate cell types by keratin expression in the developing human prostate

Prostate

Volumn 34, Issue 4, 1998, Pages 292-301

  Xue, Yong ^a   Smedts, Frank ^b   Debruyne, Frans M J ^a   De La Rosette, Jean J M C H ^a   Schalken, Jack A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Found Collaborating Hospitals E G ^*  (Netherlands)

Author keywords

Benign prostatic hyperplasia; Embryology; Etiology; Immunohistochemistry; Intermediate filament; Maturation

Indexed keywords

KERATIN;

ANTIBODY SPECIFICITY; ARTICLE; AUTOPSY; CANCER CELL; CASE REPORT; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SCHOOL CHILD;

ADULT; CELL SEPARATION; HUMANS; IMMUNOPHENOTYPING; KERATINS; MALE; PROSTATE;

EID: 0031897190     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J     Document Type: Article

References (35)

1. Barry M: Epidemiology and natural history of BPH. In Cockett A, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): Proceedings: "The Third International Consultation on Benign Prostatic Hyperplasia (BPH)." Paris: Scientific Communication International, 1995:19-50.
2. McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 1978;15:340-345.
3. Freeman MR, Chung LWK: Stromal-epithelial interactions: Molecular aspects and relevance to benign prostatic hyperplasia. In Kirby R, McConnell J, Fitzpatrick J, Roehrborn C, Boyle P (eds): "Textbook of Benign Prostatic Hyperplasia." Oxford: ISIS, 1996: 57-84.
4. Cunha GR: Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994;74:1030-1044.
5. Griffiths K, Coffey D, Cockett A, Di Sant'Agnese A, Ichikawa T, Krieg M, Lee C, McKeehan W, Schalken J, Sciarra F, Steiner G, Sugimura Y, Yamanaka H: The regulation of prostatic growth. In Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): "Proceedings: The Third International Consultation on Benign Prostatic Hyperplasia (BPH)." Paris: Scientific Communication International, 1995:73-121.
6. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
7. Ramaekers FCS, Smedts F, Vooijs PG: Keratins as differentiation markers in tumor biology and surgical pathology. In Spandidos D (ed): "Current Perspectives on Molecular and Cellular Oncology," Vol 1. London: JAI Press Ltd., 1992:285-318.
8. Nagle RB: A review of intermediate filament biology and their use in pathologic diagnosis. Mol Biol Rep 1994;19:3-21.
9. Sherwood ER, Theyer G, Steiner G, Berg LA, Kozlowski JM, Lee C: Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate. Prostate 1991;18:303-314.
10. Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM, Lane EB: Antibody markers of basal cells in complex epithelia. J Cell Sci 1990;97:39-50.
11. Brawer MK, Peehl DM, Stamey TA, Bostwick DG: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985;45:3663-3667.
12. Mao P, Angrist A: The fine structure of the basal cell of human prostate. Lab Invest 1966;15:1768-1782.
13. Timms BG, Chandler JA, Sinowatz F: The ultrastructure of basal cells of rat and dog prostate. Cell Tissue Res 1976;173:543-554.
14. Prins GS, Birch L: The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 1995;136:1303-1314.
15. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal hyperplastic, and neoplastic human prostate: Simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994;25:42-46.
16. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA: Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988;13:25-38.
17. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA: Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992;52:6182-6187.
18. Xue Y, Smedts F, Umbas R, Aalders TW, Defaruyne FMJ, de la Rosette JJMCH, Schalken JA: Changes in keratin expression during the development of benign prostatic hyperplasia (BPH). Eur Urol 1997;32:332-338.
19. Isaacs JT, Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate 1989;Supp 2:33-50.
20. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P: Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987;170:235-249.
21. van de Voorde W, Baldewijns M, Lauweryns J: Florid basal cell hyperplasia of the prostate. Histopathology 1994;24:341-348.
22. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S: Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol 1992;421:157-161.
23. Kwaspen F, Smedts F, Blom J, Pronk A, Kok MJ, van Dijk M, Ramaekers F: Periodic acid as a nonenzymatic enhancement technique for detection of cytokeratin immunoreactivity in routinely processed carcinomas. Appl Immunohistochem 1993;1: 143-148.
24. Ichihara I, Pelliniemi LJ: Ultrastructure of the basal cell and the acinar capsule of rat ventral prostate. Anat Anz 1975;138:355-364.
25. Aumüller G: Morphologic and endocrine aspects of prostatic function. Prostate 1983;4:195-214.
26. Wernert N, Seitz G, Achtstatter T: Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 1987;182:617-626.
27. Evans GS, Chandler JA: Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 1987;11:339-351.
28. Kinbara H, Cunha GR, Boutin E, Hayashi N, Kawamura J. Evidence of stem cells in the adult prostatic epithelium based upon responsiveness to mesenchymal inductors. Prostate 1996;29: 107-116.
29. Aumüller G: Postnatal development of the prostate. Bull Assoc Anat (Nancy) 1991;75:39-42.
30. Delmas V, Dauge MC: Embryology of the prostate. In Khoury S (ed): "Urology: Prostate Cancer." Boissy le cutté: FIIS, 1990:65-69.
31. Kellokumpu Lehtinen P, Santii R, Pelliniemi LJ: Correlation of early cytodifferentiation of the human fetal prostate and Leydig cells. Anat Rec 1980;196:263-273.
32. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994;24:114-118.
33. Devaraj LT, Bostwick DG: Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 1993;17:645-659.
34. English HF, Santen RJ, Isaacs JT: Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987;11:229-242.
35. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model. Prostate 1996;28:98-106.